Prostate-specific antigen screening can be beneficial to younger and at-risk men

被引：1
|
作者：
Roobol, Monique J. [1 ]
Bangma, Chris H. [1 ]
Loeb, Stacy [2 ]
机构：
[1] Erasmus Univ, Dept Urol, Med Ctr, NL-3000 DR Rotterdam, Netherlands
[2] NYU, Dept Urol, New York, NY USA
来源：
CANADIAN MEDICAL ASSOCIATION JOURNAL | 2013年 / 185卷 / 01期
关键词：
RANDOMIZED CONTROLLED-TRIAL; SERVICES TASK-FORCE; FOLLOW-UP; RADICAL PROSTATECTOMY; CANCER MORTALITY; COMPLICATIONS; PROGRAM; TIME; LIFE;
D O I：
10.1503/cmaj.111962
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：47 / 51
页数：5
相关论文
共 50 条
  • [21] Body mass index does not alter prostate-specific antigen or percent free prostate-specific antigen in men undergoing prostate cancer screening
    Hutterer, Georg C.
    Perrotte, Paul
    Gallina, Andrea
    Walz, Jochen
    Jeldres, Claudio
    Traumann, Miriam
    Suardi, Nazareno
    Benard, Francois
    Valiquette, Luc
    Mc Cormack, Michael
    Graefen, Markus
    Montorsi, Francesco
    Karakiewicz, Pierre I.
    JOURNAL OF UROLOGY, 2007, 177 (04): : 628 - 629
  • [22] Body mass index does not predict prostate-specific antigen or percent free prostate-specific antigen in men undergoing prostate cancer screening
    Hutterer, Georg
    Perrotte, Paul
    Gallina, Andrea
    Walz, Jochen
    Jeldres, Claudio
    Traumann, Miriam
    Suardi, Nazareno
    Saad, Fred
    Benard, Francois
    Valiquette, Luc
    McCormack, Michael
    Graefen, Markus
    Montorsi, Francesco
    Karakiewicz, Pierre I.
    EUROPEAN JOURNAL OF CANCER, 2007, 43 (07) : 1180 - 1187
  • [23] A Risk-Stratified Approach to Prostate-Specific Antigen Screening
    Keto, Christopher J.
    Freedland, Stephen J.
    EUROPEAN UROLOGY, 2011, 59 (04) : 506 - 508
  • [24] Prostate-specific antigen velocity based risk-adapted discontinuation of prostate cancer screening in elderly men
    Tang, Ping
    Sun, Leon
    Uhlman, Matthew A.
    Robertson, Cary N.
    Polascik, Thomas J.
    Moul, Judd W.
    BJU INTERNATIONAL, 2011, 108 (01) : 44 - 48
  • [25] Prostate-specific antigen screening: pro
    Loeb, Stacy
    Catalona, William J.
    CURRENT OPINION IN UROLOGY, 2010, 20 (03) : 185 - 188
  • [26] Improving Prostate-Specific Antigen Screening
    Strope, Seth A.
    Andriole, Gerald L.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15) : 2491 - 2492
  • [27] Evaluating the Combined Effect of Comorbidity and Prostate-Specific Antigen Kinetics on the Risk of Death in Men After Prostate-Specific Antigen Recurrence
    Wo, Jennifer Y.
    Chen, Ming-Hui
    Nguyen, Paul L.
    Renshaw, Andrew A.
    Loffredo, Marian J.
    Kantoff, Philip W.
    D'Amico, Anthony V.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (35) : 6000 - 6005
  • [28] Screening for prostate cancer using prostate-specific antigen testing in Japanese men on hemodialysis
    Kurahashi, Toshifumi
    Miyake, Hideaki
    Shinozaki, Masashi
    Oka, Nobutoshi
    Takenaka, Atsushi
    Hara, Isao
    Matsumura, Yosuke
    Fujisawa, Masato
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2008, 40 (02) : 345 - 349
  • [29] Can We Stop Ordering Prostate-Specific Antigen Screening Tests?
    Katz, Mitchell H.
    JAMA INTERNAL MEDICINE, 2013, 173 (10) : 847 - 848
  • [30] Population-based analysis of prostate-specific antigen (PSA) screening in younger men (<55 years) in Australia
    Ranasinghe, Weranja K. B.
    Kim, Simon P.
    Lawrentschuk, Nathan
    Sengupta, Shomik
    Hounsome, Luke
    Barber, Jim
    Jones, Richard
    Davis, Paul
    Bolton, Damien
    Persad, Raj
    BJU INTERNATIONAL, 2014, 113 (01) : 77 - 83
12345